CJC-1295 with DAC — long-acting GHRH analog with Drug Affinity Complex modification. Extended half-life for weekly research dosing.

CJC-1295 with DAC is the long-acting variant of CJC-1295. The Drug Affinity Complex (DAC) modification enables irreversible binding to serum albumin, dramatically extending half-life.
DAC contains a maleimidopropionic acid moiety that forms a covalent bond with cysteine-34 of serum albumin in vivo. This ‘piggyback’ on albumin extends half-life from ~30 min (no DAC) to approximately 8 days.
Used in: long-acting GHRH research, weekly dosing protocol studies, comparative DAC vs no-DAC kinetics, sustained GH research.
| Compound | CJC-1295 with DAC |
| Available Strengths | 2mg, 5mg |
| Purity | ≥99% (verified by HPLC) |
| Form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Reconstitution | Bacteriostatic water (sold separately) |
| Shelf Life | 36 months (lyophilized, properly stored) |
| Certificate of Analysis | Available upon request — contact us |
Add bacteriostatic water slowly. Use within 28 days.
Lyophilized: -20°C. Reconstituted: 2-8°C.
For research use only. Not for human consumption.